Citation Impact
Citing Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards – a cluster randomized controlled trial
2007
Epidemiology and causes of preterm birth
2008 Standout
No health without mental health
2007 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders?
2001
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups
2007 Standout
Why Most Published Research Findings Are False
2005 Standout
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
2011
A UK Audit of Screening for the Metabolic Side Effects of Antipsychotics in Community Patients
2006
Schizophrenia
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
2014 Standout
Perinatal Depression
2005 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Progressive Statistics for Studies in Sports Medicine and Exercise Science
2008 Standout
A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
2003
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
The metabolic syndrome and schizophrenia
2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
The biochemical and clinical course of postpartum thyroid dysfunction: the treatment decision
2001
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum
2001
A decision analysis model to assess the feasibility of the early detection of psychosis in the general population
2004
Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare
2009
Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement
2000
Adverse Effects of Atypical Antipsychotics
2007
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
2000 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
1999
The new and evolving pharmacotherapy of schizophrenia
2003
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Downregulation of BDNF mRNA in the Hippocampal Dentate Gyrus after Re-exposure to Cues Previously Associated with Footshock,
2002
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
2009 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
2003
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Adherence to Medication
2005 Standout
Thyroid Peroxidase Antibodies in Early Pregnancy: Utility for Prediction of Postpartum Thyroid Dysfunction and Implications for Screening
2004
Diabetes and schizophrenia 2005: are we any closer to understanding the link?
2005
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
2010 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care
2006 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
2000
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Obesity and Metabolic Syndrome in a Psychiatric Rehabilitation Service
2007
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Postpartum Thyroiditis
2002
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
2010 Standout
Postpartum Thyroiditis and Autoimmune Thyroiditis in Women of Childbearing Age: Recent Insights and Consequences for Antenatal and Postnatal Care
2001
Works of Tim Lambert being referenced
A preliminary report: a new scale to identify the pseudodementia syndrome
1998
Risperidone versus haloperidol: I. meta-analysis of efficacy and safety
1998
The Australian multicentre double‐blind comparative study of remoxipride and thioridazine in schizophrenia
1994
Risperidone versus haloperidol: II. Cost-effectiveness
1998
Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity
1999
The Art and Science of Switching Antipsychotic Medications, Part 2
2007
Summary Australian and New Zealand Clinical Practice Guideline for the Treatment of Schizophrenia 2003
2003
Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement
2004
A preliminary report: a new scale to identify the pseudodementia syndrome
1998
Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care
2009